| pubmed-article:11013360 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0063695 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C1332712 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C1282907 | lld:lifeskim |
| pubmed-article:11013360 | lifeskim:mentions | umls-concept:C0175630 | lld:lifeskim |
| pubmed-article:11013360 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:11013360 | pubmed:dateCreated | 2000-10-17 | lld:pubmed |
| pubmed-article:11013360 | pubmed:abstractText | Despite published reports regarding the association of elevated circulating CD44 and CD54 levels with unfavorable outcome in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL), little is known about therapy-related changes in either adhesion molecule. In an attempt to evaluate the effect of interferon-alpha (IFNalpha), the authors measured serum CD44 (sCD44) and sCD54 in 22 low grade NHL and 14 CLL patients. | lld:pubmed |
| pubmed-article:11013360 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11013360 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11013360 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11013360 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11013360 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:AkaiMM | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:IlhanOO | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:LUXDD | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:BeksaçMM | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:OzcanMM | lld:pubmed |
| pubmed-article:11013360 | pubmed:author | pubmed-author:AratMM | lld:pubmed |
| pubmed-article:11013360 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11013360 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11013360 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:11013360 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11013360 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11013360 | pubmed:pagination | 1474-81 | lld:pubmed |
| pubmed-article:11013360 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:meshHeading | pubmed-meshheading:11013360... | lld:pubmed |
| pubmed-article:11013360 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11013360 | pubmed:articleTitle | Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment. | lld:pubmed |
| pubmed-article:11013360 | pubmed:affiliation | Ankara University, School of Medicine, Ibni Sina Hospital, Department of Hematology, Sihhiye, Ankara, Turkey. mbeksac@ato.org.tr | lld:pubmed |
| pubmed-article:11013360 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11013360 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11013360 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
